HONG KONG – China has launched a two-invoice system for drug procurement as part of a change that underscores an ongoing reshuffle of the health care industry in the country. By limiting the number of invoices allowed in the drug distribution chain, the system aims to eliminate middlemen, avoid unnecessary invoicing that may facilitate corruption and increase transparency in drug pricing.
HONG KONG – The largest Chinese acquisition to date of a North American drugmaker – last week's $820 million acquisition of Dendreon Corp. by Sanpower Group Co. Ltd. – underscores the growing importance of Chinese financing in the global drug development market.
HONG KONG – The sentencing of a former CFDA official to a prison term may be a sign that the country is getting serious about tightening supervision of its vaccine products.
HONG KONG – The sentencing of a former CFDA official to a prison term may be a sign that the country is getting serious about tightening supervision of its vaccine products.
HONG KONG – Beijing-based Yisheng Biopharma Co. Ltd. said its PIKA rabies vaccine, which uses Toll-like receptor-3 (TLR-3) activation technology, has received the designation, which the company sees as a great push to bring the vaccine to market.
HONG KONG – The largest Chinese acquisition to date of a North American drugmaker – this week's $820 million acquisition of Dendreon Corp. by Sanpower Group Co. Ltd. – underscores the growing importance of Chinese financing in the global drug development market.
HONG KONG – Looking to cope with an aging population and a rising disease burden, the highest levels of government in China are now focused on upgrading the country's health care industries with pharma and medical devices at the top of the list.
HONG KONG – Pfizer Inc. (NYSE:PFE) will partner with Suzhou-based Pegbio Co. Ltd. to develop glucokinase activator (GKA) drugs for China as part of the multinational's strategy of using local partners to further the development of innovative drugs that address unmet needs in China.
